Fresh from External Manufacturing Leaders in snowy Boston, in this episode we are sharing insights from senior biopharma executives confronting an impossible challenge: how do you reshore when there's nowhere to reshore to?

Highlights of the event include why biotechs built on Chinese manufacturing economics are scrambling, why US capacity for ADCs and sterile fill-finish is completely tied up, and how manual operations are threatening American competitiveness.

Plus: the 2026 strategies leaders are actually implementing, from AI-powered Digital Twins to creative redundancy plays.

Thanks to Aenova Group for co-hosting ExM Leader Boston with us.

Download the full report here:

https://pharmasource.global/content/resources/exm-leaders-boston-26/